| Epidemiological, clinical and virological characteristics of four cases of monkeypox support transmission through sexual contact, Italy, May 2022 A Antinori, V Mazzotta, S Vita, F Carletti, D Tacconi, LE Lapini, ... Eurosurveillance 27 (22), 2200421, 2022 | 541 | 2022 |
| Monkeypox virus isolation from a semen sample collected in the early phase of infection in a patient with prolonged seminal viral shedding D Lapa, F Carletti, V Mazzotta, G Matusali, C Pinnetti, S Meschi, ... The Lancet Infectious Diseases 22 (9), 1267-1269, 2022 | 197 | 2022 |
| European recommendations for the management of healthcare workers occupationally exposed to hepatitis B virus and hepatitis C virus V Puro, G De Carli, S Cicalini, F Soldani, U Balslev, J Begovac, ... Eurosurveillance 10 (10), 11-12, 2005 | 181 | 2005 |
| Cardiovascular risk and dyslipidemia among persons living with HIV: a review P Maggi, A Di Biagio, S Rusconi, S Cicalini, M D’Abbraccio, G d’Ettorre, ... BMC infectious diseases 17, 1-17, 2017 | 167 | 2017 |
| Clinical review: new technologies for prevention of intravascular catheter-related infections S Cicalini, F Palmieri, N Petrosillo Critical Care 8, 1-6, 2003 | 118 | 2003 |
| Pathogenesis of HIV‐related pulmonary hypertension AM Pellicelli, F Palmieri, S Cicalini, N Petrosillo Annals of the New York Academy of Sciences 946 (1), 82-94, 2001 | 96 | 2001 |
| Infective endocarditis in patients with human immunodeficiency virus infection S Cicalini, G Forcina, FG De Rosa Journal of Infection 42 (4), 267-271, 2001 | 92 | 2001 |
| Humoral and cellular immune response elicited by mRNA vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in people living with human … A Antinori, S Cicalini, S Meschi, V Bordoni, P Lorenzini, A Vergori, ... Clinical Infectious Diseases 75 (1), e552-e563, 2022 | 77 | 2022 |
| Immunogenicity to COVID-19 mRNA vaccine third dose in people living with HIV A Vergori, A Cozzi Lepri, S Cicalini, G Matusali, V Bordoni, S Lanini, ... Nature Communications 13 (1), 4922, 2022 | 73 | 2022 |
| Effectiveness of dolutegravir‐based regimens as either first‐line or switch antiretroviral therapy: data from the Icona cohort A Mondi, A Cozzi‐Lepri, A Tavelli, S Rusconi, F Vichi, ... African Journal of Reproduction and Gynaecological Endoscopy 22 (1), 2019 | 68 | 2019 |
| Pulmonary hypertension associated with HIV infection: pulmonary vascular disease: the global perspective S Almodovar, S Cicalini, N Petrosillo, SC Flores Chest 137 (6), 6S-12S, 2010 | 67 | 2010 |
| Infective endocarditis in intravenous drug users from Italy: the increasing importance in HIV-infected patients FG De Rosa, S Cicalini, F Canta, S Audagnotto, E Cecchi, G Di Perri Infection 35, 154-160, 2007 | 63 | 2007 |
| COVID‐19 in people living with HIV: clinical implications of dynamics of the immune response to SARS‐CoV‐2 A Mondi, E Cimini, F Colavita, S Cicalini, C Pinnetti, G Matusali, R Casetti, ... Journal of medical virology 93 (3), 1796-1804, 2021 | 58 | 2021 |
| Smoking and HIV: time for a change? N Petrosillo, S Cicalini BMC medicine 11, 1-4, 2013 | 54 | 2013 |
| Post-exposure prophylaxis of HIV infection in healthcare workers: recommendations for the European setting V Puro, S Cicalini, GD Carli, F Soldani, F Antunes, U Balslev, J Begovac, ... European Journal of epidemiology 19, 577-584, 2004 | 54 | 2004 |
| Pulmonary hypertension and human immunodeficiency virus infection: epidemiology, pathogenesis, and clinical approach S Cicalini, S Almodovar, E Grilli, S Flores Clinical microbiology and infection 17 (1), 25-33, 2011 | 53 | 2011 |
| Pulmonary cryptosporidiosis in an AIDS patient: successful treatment with paromomycin plus azithromycin F Palmieri, S Cicalini, N Froio, EB Rizzi, D Goletti, A Festa, G Macri, ... International journal of STD & AIDS 16 (7), 515-517, 2005 | 49 | 2005 |
| Role of testosterone in SARS-CoV-2 infection: A key pathogenic factor and a biomarker for severe pneumonia M Camici, P Zuppi, P Lorenzini, L Scarnecchia, C Pinnetti, S Cicalini, ... International Journal of Infectious Diseases 108, 244-251, 2021 | 41 | 2021 |
| Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial M Fabbiani, R Gagliardini, N Ciccarelli, E Quiros Roldan, A Latini, ... Journal of Antimicrobial Chemotherapy 73 (7), 1955-1964, 2018 | 40 | 2018 |
| Genotypic resistance test in proviral DNA can identify resistance mutations never detected in historical genotypic test in patients with low level or undetectable HIV-RNA M Zaccarelli, MM Santoro, D Armenia, V Borghi, W Gennari, C Gori, ... Journal of Clinical Virology 82, 94-100, 2016 | 40 | 2016 |
